The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...
Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
The FDA has approved a third respiratory syncytial virus vaccine for high-risk adults aged younger than 50 years — a ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Parents and caregivers can attest: feeding a baby is no easy feat, and often comes with a learning curve. In the wake of the ByHeart formula recall and the recent infant botulism outbreak linked to ...
Although FDA Commissioner Marty Makary promised “an exciting treatment” for autism, what the agency delivered was a label expansion for leucovorin to treat the ultrarare cerebral folate deficiency.
FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.
The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...
The FDA has now approved a new drug, the hormone-free medication Lynkuet, that is used to help treat hot flashes and night sweats brought on by menopause. NBC’s medical contributor Dr. Natalie Azar ...
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic reticulum serves as a transport hub and lysosomes help with waste disposal.
The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...